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Abstract Alu sequences are frequently encountered during 
study of human genomic nucleic acid and form a major 
component of repetitive DNA. This review describes the origin 
of Alu sequences and their subsequent amplification and 
evolution into distinct subfamilies. In recent years a number of 
different functional roles for Alu sequences have been described. 
The multiple influences of Alu sequences on RNA polymerase II-
mediated gene expression and the presence of Alu sequences in 
RNA polymerase Ill-generated transcripts are discussed. 
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1. Alu sequences are repetitive DNA 
Repetitive DNA accounts for at least 20% of the human 
genome, and has been classified into several different types 
that include four principal families of interspersed repeats; 
Alu, Line 1, MIR and MaLR [1]. An estimated 0.5-1.1 X 106 
Alu sequences represent around 6-13% of human genomic 
DNA. They were named after the Alul restriction enzyme 
site within the consensus Alu sequence [2]. 
Consensus Alu sequences are approximately 280 bp in 
length, and consist of two similar, but distinct monomers 
linked by an oligo-d(A) tract (Fig. 1). The right Alu monomer 
contains a 31 bp insert absent from the left monomer. A 
functional two box (A and B) RNA polymerase (pol III) 
promoter (type 2) is present in the left monomer, but is absent 
from the right monomer [3,4]. Alu sequences do not them-
selves include a d(T)4 RNA pol III terminator, although 
one is often present in the flanking downstream genomic se-
quence. At the designated 3' end of the Alu transcript there is 
a oligo-d(A) of variable length. Newly retrotransposed Alu 
sequences are flanked by direct repeats of host sequence, 
which is consistent with insertion into staggered nicks in the 
DNA [5,6]. Alu sequences are restricted to humans and other 
primates [7,8]. 
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2. The origins of Alu sequences 
Alu sequences are postulated to be retrotransposons that 
have inserted into the human genome via a single-stranded 
RNA intermediate generated by RNA pol III transcription 
[9]. The mechanisms and factors controlling retro transposition 
are very poorly understood [10-13]. Structural homology ex-
ists between Alu sequences and human 7SL RNA, an abun-
dant cytoplasmic moiety that is conserved among eukaryotic 
taxa [14]. The 300 bp 7SL RNA is an essential component of 
the signal recognition particle (SRP), which mediates the 
translocation of secretory proteins across endoplasmic reticu-
lum. 
A model for formation of the original Alu sequence has 
been proposed on the basis of statistical analysis of nucleotide 
variation at specific sites, and phylogenetic studies (Fig. 1). 
The fossil Alu monomer (FAM) was formed by deletion of 
the central 'S-domain' from 7SL RNA and addition of a 3'-
d(A) tract which may have facilitated reverse transcription of 
RNA pol III transcripts. FAMs remain in low copy number 
in the human genome [15]. The free left arm monomer 
(FLAM) arose by deletion of 42 bp from FAM, and subse-
quently developed into subfamily A, and the evolutionarily 
younger subfamily C. BC200 RNA, a conserved cytoplasmic 
RNA pol III transcript of unknown function restricted to 
neural cells, also developed from FLAM [8,16]. Of lower 
abundance than FLAM within the human genome are copies 
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Fig. 1. Proposed model of dimeric Alu formation via intermediate 
monomeric units derived from 7SL RNA which is neither capped 
nor polyadenylated. Important nucleotide positions are marked on 
the schematic 7SL RNA moiety. See text for explanation of the 
progression from 7SL RNA to the first dimeric Alu repeat. The ap-
proximate positions and consensus sequences of the RNA pol III 
promoter boxes A and B in the Alu are marked. 
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of the free right arm monomer (FRAM) which arose by dele-
tion of 11 bp from F AM. The first Alu sequence was appar-
ently formed by dimerisation of a subfamily C FLAM and a 
FRAM, although the mechanism by which this occurred is 
unclear [8,15,17]. 
3. Evolution of Alu sequences 
Subsequent to formation of the first Alu repeat there has 
been a massive, but time-restricted amplification of Alu retro-
transposons within the human genome [10]. This contrasts to 
a limited amplification of both their monomeric and 7SL 
RNA precursors. The conservation of 7SL RNA across all 
species suggests that monomeric precursors of Alu sequences 
were present in all lineages. 
Statistical analysis has identified key diagnostic nucleotide 
positions in Alu sequences that define 12 subfamilies. A con-
sensus nomenclature for Alu subfamilies has been agreed [18] 
(Fig. 2). As more sequences become available for analysis it is 
possible that further Alu subfamilies may be identified. Phy-
logenetic studies of orthologous primate loci indicate that Alu 
subfamilies were sequentially inserted into the genome. To-
gether with computer modelling this has allowed estimations 
of Alu subfamily age [19-21] (Fig. 2). 
Amplification of Alu subfamilies has not occurred at a con-
stant rate throughout evolution. The majority of Alu retro-
transpositions were completed at least 30 million years ago 
when the Alu-Sx subfamily, which accounts for half of all 
human Alu sequences, and the Alu-Sp and Alu-Sq subfamilies 
became unable to replicate [20]. Alu retrotransposition still 
continues in the youngest subfamilies, but is a rare event 
[22]. There are only around 1500 Alu-Yb8 elements in the 
haploid human genome [23]. Retrotransposition of a few 
Alu sequences has occurred so recently that they are not yet 
fixed within the human genome [1,18]. The reasons for the 
differential rate of Alu insertion are unknown, which again 
emphasises how little is understood about retrotransposition 
[1,24]. 
The vast majority of Alu sequences are believed to be un-
able to act as templates for further Alu expansion within the 
human genome for two main reasons. Firstly, a large number 
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Fig. 2. The proposed evolution of the 12 Alu subfamilies. Numbers 
in parentheses represent approximate times (in millions of years) of 
insertion of different subfamilies into the human genome. See text 
for a more complete explanation and related references. 
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Fig. 3. Proposed evolving master gene model of Alu subfamily for-
mation. Adapted from [25]. See text for explanation. 
of Alu sequences are truncated, particularly at the 5'-end. 
Secondly, many Alu sequences have only 70-80% homology 
with their respective subfamily consensus sequences [25]. This 
has lead to formulation of a 'master gene' model of Alu for-
mation (Fig. 3), in contrast to the 'random template' model 
where all Alu sequences within the human genome are able to 
act as templates for Alu expansion. 
In the master gene model, a highly restricted number of 
'master' genes have been retrotransposed many times [25]. A 
mutation in a master gene generated a new Alu subfamily 
master gene, with subsequent progeny distinguished by this 
new key mutation. The progeny Alu sequences underwent 
multiple independent mutations, and so diverged from the 
master gene consensus sequence. 
The high rate of independent mutations observed in prog-
eny Alu sequences can be attributed to a combination of sev-
eral factors. Newly retrotransposed Alu sequences are CG rich 
(approximately 65% of their nucleotides), have a high percent-
age of dCpG doublets compared to other human DNA (9% 
versus less than 1%) and are extensively methylated [26-28]. 
Twenty-six dCpG doublets were identified in a recently retro-
transposed Alu sequence, and it has been estimated that nearly 
a third of all human dCpG doublets occur within Alu sequen-
ces [29,30]. Methylated dCpG doublets mutate at a higher rate 
compared to other nucleotide positions, with 5-methyldeoxy-
cytidine (5-medC) deaminated to generate either dTpG or 
dCpA [26]. Of relevance to the study of Alu sequences was 
the recent observation that 5-medC deamination is 1250-fold 
slower in vivo compared to in vitro [31]. Many old Alu se-
quences have lost most of their dCpG motifs [27]. By contrast, 
Alu master genes are assumed not to be extensively methyl-
ated as they must be able to conserve their dCpG doublets. 
This hypothesis is supported by the observation that the 
BC200 gene, which evolved from FLAM, contains eight 
dCpG doublets [8,32]. 
5-medC deamination is an important, but not exclusive 
cause of Alu sequence variation. Random nucleotide muta-
tions probably account for a significant proportion of se-
quence variability, particularly in older Alu sequences. There 
is much greater drift from the consensus subfamily sequences 
in old compared to young Alu sequences. In addition, there is 
the potential for the introduction of nucleotide mutations 
during Alu retrotransposition as RNA pol III and reverse 
transcriptase have higher error rates than DNA polymerases 
[33]. However, in reality this is probably only a minor source 
of nucleotide variation. 
It is apparent that at several time points during evolution 
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there was concurrent retrotransposition of more than one Alu 
subfamily. This may indicate either the presence of multiple 
active master genes, possibly at a single locus, or allelic var-
iation in a single master gene [25,34]. Clearly, only Alu se-
quences retrotransposed in germ cells can be passed from 
generation to generation. In theory, Alu retrotransposition 
may also occur in somatic cells, but whether this occurs and 
of what significance it would be remain unclear. 
Very rarely, other mechanisms contribute to Alu placement 
within the human genome. For example, comparison of or-
thologous loci in the low density lipoprotein receptor genes of 
primates revealed that an old, highly mutated Alu repeat 
present in primates had been replaced by a young Alu-Yb8 
repeat in humans [35]. This represented changes at 16 diag-
nostic nucleotide positions and included three separate dupli-
cation-deletion events. The donor Alu-Yb8 may have been 
either single- or double-stranded nucleic acid. Alternatively, 
a new Alu-Yb8 repeat may have been inserted into the d(A) 
tract of the existing old Alu, after which a homologous, but 
unequal crossover event occurred with one of the alíeles lost 
and not passed to the next generation. 
4. Functions of Alu sequences 
The functional role of most Alu sequences remains 
contentious. Alu sequences have been considered as either 
'junk', 'parasitic' or 'selfish' DNA that served no useful func-
tion, yet was not detrimental to the host [36,37]. Conversely, 
the persistence over a long time period of putative Alu master 
genes in low copy number implied a useful function. Other-
wise mutational inactivation and selective clearance from the 
genome would have occurred [25]. 
If Alu sequences have an important function this implies 
that non-primates either lack this function, or have compen-
satory mechanisms. The great variation within copy number 
in some SINE families among related species such as rat and 
Chinese hamster suggested that many retrotransposed SINEs 
do not have a critical role [38]. The genome of the puffer fish 
(Fugu rubripes) is 7.5-fold smaller than the human genome, 
but many genes are conserved between the two species. The 
smaller puffer fish genome is the result of shorter intergenic 
and intronic sequences, and less repetitive DNA. This sug-
gested again that much of the repetitive DNA in humans 
was redundant [39]. However, within the organised structure 
of the human genome, it seemed unlikely that all Alu sequen-
ces were totally functionless and this has now been confirmed. 
5. Frequency and distribution of Alu sequences 
Alu sequences occur at an average of one every 3-6 kbp, 
but distribution within the human genome is not uniform. 
Alu-rich regions are recognised, yet it remains unknown if 
these reflect either specific functions or regions where Alu 
sequences exert minimal detrimental effects. For example, 
just telomeric to the Bat2 gene in the HLA class III locus, 
there are 42 Alu repeats at a density of 1.9 Alu repeats per kbp 
[40]. Accordingly, there are also regions where Alu sequences 
are sparse. 
6. Alu sequences are rare in protein-coding exons 
Alu repeats are rarely present in protein-coding regions of 
mature mRNA and controversy has surrounded certain exons 
that appear to include Alu elements [41^14]. Alu sequences 
contain many stop codons in both sense and antisense direc-
tions that would result in a truncated protein. One such ex-
ample is a case of haemophilia B caused by introduction of an 
Alu- Ya5 element into a protein coding exon of the factor IX 
gene [45]. In the few functional mRNA moieties that contain a 
protein coding Alu sequence, the mRNA is often of low abun-
dance compared to other splice variants of the same gene that 
lack the Alu cassette [46,47]. For example, only about 10% of 
decay accelerating factor mRNA included a protein-coding 
Alu-Sc cassette [48]. The presence of Alu-J cassettes in some 
splice variants of biliary glycoprotein mRNA indicated a 
long-standing tolerance of protein coding Alu elements [49]. 
7. Alu sequences occur frequently in heterogeneous nuclear 
RNA 
Although Alu sequences are rare in protein-coding exons, 
they more commonly occur within the non-coding regions of 
mature mRNAs. An Alu sequence was identified in 5% of 
1616 human full-length cDNAs, with 82% and 14% of these 
located in 3'-UTR and 5'-UTR respectively [44]. In addition, 
Alu sequences frequently occur within introns, and so are 
present in heterogeneous nuclear RNA. These Alu sequences 
can have a dramatic impact on gene expression. Alu sequen-
ces, particularly in the antisense direction, contain several re-
gions that differ from either consensus donor or acceptor 
splice site sequences by either one or two nucleotides [47]. 
Normal mRNA splicing can be disrupted by point mutation 
in existing intronic Alu elements with activation of cryptic 
splice sites and subsequent formation of abnormal protein 
products and clinical disease including Alport syndrome and 
gyrate atrophy of the choroid and retina [50,51]. Normal 
mRNA splicing can also be disrupted by retrotransposition 
of an Alu element into an intron, with formation of a trun-
cated, abnormal protein, such as in a reported case of neuro-
fibromatosis [52]. 
8. Alu sequences influence normal gene expression 
Alu sequences can influence normal gene expression [53,54]. 
For example, young subfamily Alu sequences include func-
tional retinoic acid response elements that potentially influ-
ence expression of several genes including the keratin K18 
gene [55]. In another example, an Alu sequence within the 
final intron of the human CD8ce gene includes four transcrip-
tion factor binding sites [56]. An upstream, antisense, mono-
meric Alu sequence in the same intron can bind the down-
stream complete Alu by formation of a cruciform structure, 
that prevents transcription factor binding, and so silences the 
CD8a gene enhancer. A significant number of genes include 
Alu sequences in their 5'-region and it is possible that some of 
these exert an effect on normal transcriptional regulation. 
9. Alu sequences are involved in chromosome rearrangements 
Once retrotransposed, it is thought that few Alu sequences 
are eliminated, although recombinations between distant Alu 
elements can occur [57]. Examples that cause disease such as 
familial hypercholesterolaemia and angioedema are recog-
nised, with Alu-Alu recombinations typically close to the 5'-
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end of the left Alu monomer [58,59]. Complex events, such as 
inversion/deletions between Alu elements, have also been iden-
tified. For example, complex homologous recombination of 
three intragene Alu elements in the GPIIIa gene of the platelet 
fibronectin receptor has caused Glanzmann's thrombasthenia, 
a hereditary bleeding disorder [60]. More subtle gene rear-
rangements also occur, such as polymorphism in the angio-
tensin-converting enzyme gene, where homozygous absence of 
a 287 bp intronic Alu sequence is associated by meta-analysis 
with an increased risk of myocardial infarction [61]. Recom-
bination events may involve distant regulatory motifs rather 
than the downstream introns and exons. For example, dele-
tion of a major, remote regulatory element controlling oc-glo-
bin expression has caused oc-thalassaemia [62]. Alu sequences 
have also been implicated in the generation of pseudogenes 
[63]. 
10. Alu sequences may have a role in genomic imprinting 
Alu sequences are highly methylated in somatic tissues and 
female germ cells, but methylation in male germ cells is re-
stricted [1,30]. Accordingly, it has been speculated that Alu 
sequences may contribute to the process of genomic imprint-
ing, the process by which maternal and paternal genes are 
selected for differential expression. Hypomethylation in the 
male germline may contribute to the preservation of dCpG 
doublets, for example in the putative Alu 'master genes', but 
the processes of genomic imprinting remain poorly under-
stood. 
11. Alu sequences as substrates for RNA pol Ill-mediated 
transcripts 
In addition to Alu sequences incorporated in RNA pol II 
transcripts as discussed earlier, a population of poorly under-
stood RNA pol III transcripts exists which contain Alu se-
quences. Single stranded RNA Alu sequences occur in the 
cytoplasm of transformed and non-transformed human cell 
lines, and normal human tissues [64—67]. Transport from the 
nucleus to the cytoplasm of these Alu transcripts and 7SL 
RNA is a competitive, facilitated process dependent upon 
the Alu sequence itself [68]. 
Two main forms of cytoplasmic RNA pol III ^/«-contain-
ing transcripts have been identified. Full-length Alu RNA 
(ñAlu RNA) includes the full-length 3'-polyadenylated Alu 
sequence, and may provide a population of moieties suitable 
for retrotransposition. Small cytoplasmic Alu RNA (scAlu 
RNA) includes a non-polyadenylated left-hand Alu monomer 
that is probably derived from processed ñAlu RNA. BC200 
RNA is also very similar to the left-hand Alu monomer, but is 
derived from the BC200 gene. All Alu subfamilies are repre-
sented in ñAlu RNA and scAlu RNA indicating origins from 
several genomic loci, but young subfamilies predominate. This 
may reflect the loss of specific control elements, such as a 
functional RNA pol III promoter as a result of nucleotide 
mutations, in older Alu subfamilies [67,69,70]. Recently, a 
genomic Alu-Ya5 sequence with transcriptional activity in vi-
tro was described, with transcription partially dependent upon 
the flanking sequences [70]. 
Despite the high numbers of Alu repeats in the human 
genome each cell typically includes less than 1000 copies 
each of ñAlu RNA and scAlu RNA [69]. However, the abun-
dance of cytoplasmic Alu transcripts in vitro can be modified 
by either viral infection, alterations in nucleotide methylation, 
heat shock or chemical manipulation. Cellular infection with a 
number of viruses caused transient accumulation of high lev-
els of cytoplasmic ñAlu RNA transcripts [71-73]. Viral gene 
expression was necessary, and increased RNA pol III tran-
scription is believed to reflect roles for certain viral proteins 
as associated transcription factors. Speculation has occurred 
about an anti-viral biological role for Alu transcripts. The Alu 
sequence is derived from, and retains a similar secondary 
structure to, the functional domain of 7SL RNA that is re-
sponsible for the protein elongation-arresting function of the 
SRP [14]. 7SL becomes a functional part of the SRP by in-
teracting with specific proteins, and Alu sequences are also 
able to bind proteins homologous to components of the 
SRP [74-77]. Accordingly, Alu transcripts complexed with 
specific proteins may have a 7SL-like function. For example, 
in viral-infected cells it has been postulated that Alu tran-
scripts complexed with protein could arrest viral and host 
protein synthesis, with prevention of viral replication and 
death of infected host cells in a mechanism reminiscent of 
that induced by interferon [27]. HeLa cell proliferation can 
be inhibited by either 7SL or Alu gene sequences in expression 
vectors [78]. 
Regulation of these ^/«-containing RNA pol III transcripts 
is likely to be influenced by several different mechanisms that 
are currently poorly understood. For example, a recent report 
described a level of control that involved wild-type p53 repres-
sion of Alu template activity in vitro and in vivo [79]. Further 
insights into the function of ^/«-containing RNA pol III tran-
scripts may eventually be gained by greater understanding of 
the function of BC200 RNA [8,16]. 
12. Conclusions 
Researchers investigating the human genome inevitably en-
counter Alu sequences. The opinion that the large number of 
Alu sequences within our genome represent the consequences 
of 'parasitic' expansion of retrotransposons with no benefit to 
the human host has been repeatedly challenged in recent 
years. However, many aspects of Alu sequence function re-
main contentious. A large number of Alu repeats may be 
'junk' DNA that confers neither benefit nor harm to the 
host. However, specific adaptive and maladaptive functions 
have been identified for an increasing number of individual 
Alu sequences. Some of these functions are critically depend-
ent on the nucleotide sequences of specific Alu cassettes, 
rather than reflecting a defined, fundamental role for all Alu 
sequences. It seems probable that further functions for Alu 
sequences will be identified in the future. 
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